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Abstract 
“To be forever young doesn’t mean to be 20. It means to be optimist, to feel good, to have 
an ideal to fight for and to achieve it” said Prof. Ana Aslan. Human ageing and longevity are 
complex and multi-factorial traits that result from a combination of environmental, genetic, 
epigenetic and stochastic factors. Ageing refers to the time sequential deterioration - including 
weaness, susceptibility to disease, loss of mobility and agility. 
 
INTRODUCTION 
Ageing  is  a  degenerative  process, 
extensively  studied  for  which  many 
theories  have  been  formulated.  Ageing  is 
the  major  biomedical  challenge  of  our 
society,  considered  as  a  progressive  and 
irreversible set of structural and functional 
changes  for  a  living organism.  The 
percentage  of  elderly  people,  the 
demographic imbalanced pyramids and the 
incidence  of  age-related  diseases  such  as 
cardio-vascular  diseases,  cancer  and 
neurodegenerative  diseases  are  main 
concerns for many scientists. 
There are 10 questions about ageing: 1) 
How  does  ageing  and  longevity  vary 
between  species?;  2)  How  does  ageing 
evolve?  3)  Are  ageing  and  longevity 
controlled by the genome? 4) Can aging be 
suppressed  and  lifespan  increased?  5) 
What is the basis of ageing and longevity? 
6) How does cellular senescence contribute 
to ageing? 7) How does ageing give rise to 
ageing-related  disease?  8)  Why  does  the 
immune system fail in ageing? 9) What are 
the  prospects  for  treatments  for  ageing? 
10)  What  should  the  aims  of  ageing 
research be? 
Healthy  ageing  should  ideally  start  in 
childhood and take a lifelong perspective. 
Yet it is never too late to start. Investing in 
prevention can have important benefits for 
the  individuals  involved  and  has  also 
societal  benefits,  since  it  is  better  to 
finance  effective  strategies  to  prevent 
diseases than to use the resources to cure 
them [6]. 
Combining  the  balneotherapy  with 
using  products  with  healthy-ageing  effect 
provides  a  significant  advantage  and 
represents  the  sustainability  of  the 
strategies for healthy ageing, in the context 
of which the spas is the ideal place for the 
application  of  new  treatments.Darwin’s 
theory proposes survival and reproductive 
capacity  as  factors  driving  evolution.  He 
assumed that all living organisms have the 
capacity for evolution, by means of natural 
selection,  and  that  this  capacity  was  a 
constant.  
Richard  Dawkins,  author  of  “Selfish 
gene”  says  that  genes  are  actually 
struggling  for  survival.  Animals  and 
humans  are  “survival  machines”  whose 
purpose  is  to  propagate  their  genes. 
Evolvability theory refers to the idea that 
populations  and  species  can  vary  in  their 
capacity  for  evolution.  Evolvability 
considerations  provide  explanations  for 
programmed  ageing  and  other  lifespan 
limiting characteristics. 
Ageing is intrinsically complex, being 
driven  by  multiple  causal  mechanisms, 
inclusive  mutations.  Each  mechanism 
tends  to  be  partially  supported  by  data 
indicating that it has a role in the overall 
cellular  and  molecular  pathways 
underlying  the  ageing  process.  Even  in  a 
population  free  of  ageing,  death  will 
nonetheless  occur,  from  extrinsic  hazards 
as disease, predators, and accidents.  
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Ageing  evolves  as  a  side  effect  of 
natural  selection  in  favour  of  mutations 
that  cause  a  benefit  during  youth  -  The 
Pleiotropy  or  Trade-off  Theory  for  the 
Evolution of Ageing. There are mutations 
that are beneficial in youth, but at the price 
of  a  higher  rate  of  ageing.  More 
individuals  will  survive  to  express  the 
early benefit than will survive to suffer the 
higher rate of ageing.  
Regarding  The  How  of  ageing 
question, one of the first theories is „The 
rate of living theory” – after which: „ the 
duration  of  life  varies  inversely  as  the 
energy  expenditure,  the  length  of  life 
depends on the rate of living” as in the case 
of Drosophyla. 
Unlocking  the  capacity  to  manipulate 
human ageing would result in great health 
benefits. Currently, health is understood as 
the  removal  of  diseases  in  a  defensive 
manner  to  the  pathological  process  and 
with higher costs. Understanding how the 
environment  modulates  ageing-related 
genes may lead to human applications and 
disease therapies through diet, lifestyle, or 
pharmacological  interventions.  The  study 
of  the  mechanisms  by  which  various 
natural  health  factors  can  influence  the 
ageing process  opens  the  path  to  design 
and  obtain  new  products  for  healthy 
ageing. 
For  the  cellular  level,  Hayflick  limit 
express  that  cell  replication  slows  and 
stops  after  about  50  passages,  becoming 
senescent. 
Research  on  healthy  ageing 
interventions  has  evolved  along  the  main 
theories  of  ageing.  Pharmacological 
intervention to decelerate ageing and age-
related  diseases  is  highly  attractive.  The 
potential for further advances in this field 
is immense; hundreds of genes in several 
pathways  have  recently  emerged  as 
regulators of ageing and caloric restriction.  
One well-studied dietary manipulation 
of  ageing  is  caloric restriction,  which 
consists  of  restricting  the  food  intake  of 
organisms without triggering malnutrition. 
Caloric restriction is already being used as 
a paradigm for developing compounds that 
mimic  its  life-extension  effects  with 
therapeutic value.  Reducing  calorie  intake 
has been shown experimentally to induce 
anti-ageing behavior in many species. 
Lifespan  extension  possibility  was 
demonstrated  for  many  geroprotector 
substances:  Gerovital  prepared  by  Ana 
Aslan,  resveratrol,  Rapamycin, 
antioxidants,  hormones,  bioregulatory 
peptides,  metformin,  fenformin  and 
adaptogens  (ginseng).  As  mechanisms 
have been observed reduced plasma levels 
of  insulin,  increased  insulin  receptor 
sensitivity,  low  body  temperature, 
cholesterol,  triglycerides,  alpha-
lipoproteins,  blood  pressure.  All  these 
processes  are  correlated  with  the 
expression  of  genes  called  sirtuins. 
Rapamycin,  described  as  an 
immunosuppressive  drug  has been shown 
to be also an anti-ageing drug whose goal 
is  the  mTOR  -  a  serine/threonine  kinase 
that  regulates  cell  growth,  viability, 
mobility,  protein  synthesis  and  gene 
transcription.  
Among  the  many  hormones  with 
geroprotector  effects,  estrogen-like  or 
testosterone-like  substances,  detected  also 
in the organic component of therapeutical 
peloids,  stimulate  or  inhibit  various 
neuroendocrine mechanisms. If insulin and 
cortisol  serum  levels  are  increasing  with 
age,  the  testosterone,  estrogen, 
progesterone, growth hormone and thyroid 
hormones  level  gradually  decrease  along 
with age, which causes progressive muscle 
atrophy,  fatigue,  osteoporosis,  reduced 
sexual function and increased fat levels.  
Free  radicals  are  continuously 
produced in the human body, as they are 
essential for energy supply, detoxification, 
chemical  signaling  and  immune  function. 
Reactive oxygen species have been found 
to play an important role in the initiation or 
progression  of  various  diseases  such  as 
atherosclerosis,  inflammatory  injury, 
cancer  and  cardiovascular  disease.  An 
imbalance  between  antioxidants  and 
reactive oxygen species results in oxidative  
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stress,  leading  to  cellular  damage.  Air 
pollutant  such  as  car  exhaust,  cigarette 
smoke,  and  industrial  contaminants 
constitute major sources of ROS that attack 
and damage the organism. 
Herbs, diet, lifestyle, and supplements 
can  slow  ageing,  enhance  memory,  help 
prevent  cancer  and  heart  disease. 
Medicinal plants (many used as spices and 
food plants) contain organic compounds as 
tannins,  alkaloids,  carbohydrates, 
terpenoids, steroids and flavonoids, which 
produce  physiological  effects. 
Antioxidants intervene in gerossuppression 
based  on  the  ageing  free  radical  theory. 
Resveratrol  present  in  grapes  and 
subsequently  in  red  wine,  is  a  natural 
phytoalexin  used  by  certain  plants  in  the 
defense  mechanism  against  pathogens. 
Resveratrol  caused  a  statistically 
significant  decrease  of  age-related 
parameters  such  as  albuminuria, 
inflammatory  level,  vascular  endothelial 
apoptosis, and the incidence of cataract, at 
rats.  A  healthy  diet  should  provide  the 
different  nutrients  one  needs  to  remain 
healthy and should give the opportunity to 
engage socially and to have a good quality 
of life. However, the precise dietary needs 
of  the  older  people  are  still  largely 
unknown. 
Peloids  used  also  in  the  treatment  of 
various  rheumatic,  endocrine, 
dermatological  or  gynecological  diseases, 
represent the support for the design of new 
geroprotectors.  "Peloidextract"  obtained 
from  Techirghiol  mud  is  a  clear  liquid, 
with  an  alkaline  pH  of  7.6  to  8,  and 
mineral content closely comparable to that 
of blood serum. Humic compounds play a 
role  in  redox  reactions,  absorption, 
complexation and transport of substances. 
Humic acids have an astringent effect, anti-
allergic,  antiviral,  antibacterial,  anti-
inflammatory, estrogenic, hyperemic, UV-
protective  and  are  heavy metal chelating-
agents. Fulvic acids have antitumoral, anti-
allergic,  antioxidant  and  antimicrobial 
activity,  acting  in  acid  medium  by 
inhibiting  mitochondrial  respiration  in 
Candida  utilis,  have  antiulcerogenic  and 
precognitive properties so they can be used 
to treat Alzheimer's disease.  
 
Theories of ageing 
 
While  earlier  theories  of  ageing  were 
centered on the level of organ dysfunction 
or  systemic  level  of  the  body,  current 
theories  put  focus  on  dysfunction  of  the 
cellular  and  molecular  mechanisms  [10]. 
Such  modern  approaches  reduced  the 
differences  between  the  existing  theories 
on the mechanism of ageing, emphasizing 
their  complementary  elements,  but  at  the 
moment  there  no  integrative  theory  [2] 
exists  for  post-reproductive  ontogenetic 
development  that  can  explain  all  the 
processes involved in the multiple aspects 
of ageing.  
Programmed  ageing  theories  are 
subdivided  into  three  conceptual 
subcategories  [2,13,14]  genetically 
programmed  longevity  theory  which 
assumes that ageing is the result of starting 
or  stopping  certain  genes,  being  included 
the role of genetic instability (shortening of 
telomeres)  in  the  dynamics  of  ageing 
processes  [14,  17];  endocrine  theory  - 
according to which ageing is governed by a 
biological  clock,  whose  function  is 
regulated  by  endocrine  mechanisms, 
including  insulin-like  growth  hormone 
IGF-1  [2,3,14];  and  immunity  theory, 
which states that the immune system can 
be  programmed  to  a  decrease  in  its 
functionality,  immunosenescence,  which 
will  lead  to  increased  susceptibility  to 
infectious  diseases  and  ageing 
[15,16,25,26].  
Theories which put the ageing process 
due to internal and external environmental 
factors  [10]  are  Wear  and  Tear  Ageing 
Theory  according  to  which  cells  and 
tissues become aged over time [2,14]; vital 
level activity theory - which states that a 
high  level  basal  metabolism  leads  to  a 
shortening  of  the  life  of  the  organism 
[2,14];  cross-linking  theory  presented  by 
Bjorksten  (1942)  according  to  which  the  
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cumulative  chemical  interchange  of 
important  macromolecules,  including 
collagen,  causes  ageing  [2,14];  somatic 
DNA damage theory [47] which considers 
that  ageing  results  from  genetic  integrity 
degradation of somatic cell as a result of 
mutations  registered  both  in  the  nucleus 
and in the mitochondria [2,13,14,44]; and 
free  radicals  theory  which  stipulates  that 
the  superoxide  and  other  free  radicals 
destroy the molecular components of cells 
and thus alter their normal function [11]. 
Considering  ageing  being  a  gradual 
loss  of  functional  adjustment  of  some 
complex  multifactorial  biological 
processes,  the  individual  genotype  surely 
has  an  impact  on  the  rate  of  ageing 
[11,12,18].  More  recent  studies  also 
include  metabolomic  approaches  towards 
identification  of  metabolite  panels  and 
potential metabolite markers indicative of 
age-related  processes,  and  include  e.g. 
amino  acids,  fatty  acids  and  steroids, 
branched-chain  amino  acids  and 
polyamines.  
In 1957 Harman proposed the idea that 
a  general  process  of  accumulation  of 
oxygen-free  radicals  negatively  affects 
internal environmental factors and changes 
genetic  factors,mechanism responsible for 
ageing and death of all living things. The 
theory  was  revised  in  1972  when  it  was 
shown  that  mitochondria  are  the  main 
center  of  several  chemical  reactions  that 
generate  free  radicals.  Reactive  oxygen 
species  (ROS)  are  probably  the  most 
significant  free  radicals  with  major 
implications in damage and cells and body 
ageing  [19,20].  Free  radical  theory  is 
currently  considered  the  most  acceptable 
explanation of ageing [19], although recent 
data obtained on a set of transgenic mutant 
SOD2
 + / - or Mclk1 
+ / -  mice disprove the 
central dogma of the theory [11]. 
The  main  bottleneck  is  the 
characterization of the rate of ageing of the 
body,  which  employs  the  concept  of 
biomarker  of  the  ageing  [21,24,27], 
defined  as  quantitative  or  qualitative 
biological  parameter  that  allows  the 
prediction  of  functional  status  of  the 
organism  to  a  particular  moment  of  its 
existence  [22,24].  Experts  in  the  field 
suggest  parameters  that  aim  the  age  of 
nervous,  cardiovascular,  respiratory  or 
excretory system. Also, they are advancing 
proposals for estimating the biological age 
of the cell. In humans, the biological age is 
surpassed  by  the  psychological  age,  the 
intellectual age and the social age. 
Several  authors  have  discussed  the 
criteria for selection of some biomarkers of 
ageing, emphasizing the following critical 
points that they should fulfill [23]: ageing 
and longevity rate  prediction, quantitative 
monitoring  the  biological  quality  of  the 
body  by  parameters  by  which  the 
determination will not harm the integrity of 
the  organism,  the  data  obtained  must  be 
reproducible and comparable for different 
species  of  laboratory  animals  and  with 
relevance  for  humans  [23,25,27,28]. 
Among the main biological markers used 
to predict the biological age and longevity, 
the  American  Federation  of  Ageing 
Research suggests as the set of biomarkers 
of ageing [27]: systolic and diastolic blood 
pressure,  the  heart  rate  at  rest,  total 
cholesterol,  HDL  and  LDL  cholesterol, 
lipid  levels,  blood  glucose,  body  mass 
index  [26],  abdominal  obesity  index,  T 
lymphocytes  level,  cortisol  level  and 
electrocardiogram. 
Allostatic  overstressing  index  [23] 
proposed by McEwen and Stellar in 1993 
denotes the body's dysfunctional response 
to  chronic  stress  and  reveals  increased 
levels  of  adrenaline,  noradrenaline  and 
dopamine  hormones  [2].  This  index  was 
used by Karlamangla and collaborators in a 
recent  study  of  mortality  in  people  aged 
over 70 years, pursued over a period of 4.5 
years.  Patients  with  an  allostatic 
overstressing  increased  index  presented  a 
much  higher  risk  of  mortality.  Thus,  the 
study concludes that a uniform increase of 
allostatic  overstressing  index  (normally 
located between -1.7 and 1.4) leads to an 
increase of 3.3 times in mortality measured 
in the range of 4.5 years.  
 Balneo Research Journal            DOI: http://dx.doi.org/10.12680/balneo.2014.1066         Vol.5, No.2, May 2014 
 
 
 
66
The  so-called  matrix  protocol  [2]  of 
ageing  biomarkers  used  by  the 
International  Institute  of  Longevity 
Montclair (New Jersey) determines the rate 
of ageing on four levels: 
I.  the  overall  functionality  of  the 
body measured by the ratio of weight and 
level of fat, flexibility, aerobic endurance, 
bone  density,  tactile  response  latency, 
forced  expiration  volume,  vision  and 
hearing [27]; 
II.  functioning  at  the  cellular  level 
monitored at the skin level by determining 
the  cytoarchitecture  changes  of  basal 
membrane, epidermal turn-over, sebaceous 
glands  architecture,  microvascular 
changes,  collagen  ratio,  elasticity  of  the 
fibers [28]; 
III.  the  molecular  level  consider  the 
growth and thyroid hormone level but also 
of  coenzyme  Q10,  sensitivity  to  insulin, 
the  heat  shock  proteins  level,  the 
oncogenes level in the blood, serum level 
of antioxidants [25]; 
IV.  at  DNA  level  is  studied  the 
position and size of telomeres (set at WBC 
level)  and  the  accumulation  level  of 
mutations in the genetic material. 
The researchers from the International 
Longevity  Institute  are  currently  working 
on  a  new  laboratory  chemistry  test  that 
should  reflect  the  damage  level  of  DNA 
and should bring science-based predictions 
regarding  the  therapeutic  value  of  anti-
ageing  interventions  through  the 
mutational  changes  occurring  in  the 
somatic genetic material [2, 28, 29].  
Telomeres  damage  can  be  assessed 
indirectly  by  measuring  some  biomarkers 
that  correlate  with  their  shortening  [28]. 
Thus,  Jiang  and  Rudolph  analyzed  the 
telomeres  shortening  mechanism  and  the 
rate of ageing in several organs and tissues, 
identifying four proteins whose expression 
increases  in  relation  to  telomere 
shortening,  as  these:  Cathelcidins  from 
macrophages  and  polymorphonuclear 
leukocyte lysosomes activated by bacterial 
infection;  chitinase  3  like3  (Chi  3L3) 
involved  in  the  initiation  of  immune 
response; elongation factor 1α (EF-1 α) - 
which controls protein synthesis in human 
fibroblasts  and  stathmins  -  which  control 
the intracellular microtubules stability, cell 
motility and mitosis [2]. 
The concept of oxidative stress caused 
by  free  radicals,  represents  the  basis  of 
taking into account biomarkers of ageing, 
physiological  and  molecular  indicators  of 
oxidative  stress.  Carbonylate  proteins 
represent,  in  this  context,  an  example  of 
the  use  of  oxidative  stress  indicators  as 
biomarkers  of  ageing  [2,25].  Many 
scientists  consider  the  accumulation  of 
protein carbonyls in erythrocyte membrane 
as  an  indirect  marker  of  ageing  and  the 
ferro-reduction  antioxidant  potential 
(FRAP) in blood plasma as an indicator of 
the body's antioxidant defense capacity [2]. 
The  oxidative  and  reductive  activity  of 
enzymes  that  act  on  glutathione, 
thioredoxin and other substrates of interest 
in the oxidation-reduction process reflects 
not  only  the  level  of  antioxidative 
protection  but  are  probably  relevant 
biomarkers  for  ageing  rate.  NADH  and 
FADH coenzymes - critical components of 
energetic  transport  in  mitochondria  may 
represent,  by  their  expression  level, 
biomarkers  of  mitochondrial  activity  and 
indirectly of senescence and body age [2]. 
Heat  shock  proteins  (HSP)  are  other 
biomarkers of ageing, and there are studies 
showing that the change of these proteins 
expression  correlates  with  changes  in 
longevity,  experimentally  described  in 
Caenorhabditis elegans [2]. 
Apolipoproteins  synthesized  in  the 
liver  and  intestine  are  involved  in  the 
transport of cholesterol and triglycerides in 
the  blood,  are  considered  more  eloquent 
predictors  of  death  by  coronary  heart 
disease [23]. 
Interleukin 6 (IL6) is a multifunctional 
cytokine  that  plays  an  essential  role  in 
acute  inflammation  stage.  Although 
normally  in  the  absence  of  inflammation 
can not be detected in blood samples over 
time  by  losing  his  regulation  expression,  
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the  expression  level  increases  with  age 
[22,23]. 
Growth  hormone,  secreted  by  the 
pituitary gland [351] has a decreasing level 
with  age  of  the  body  being  registered  a 
decrease  by  14%  every  decade  after  the 
age of 20-25 years and reaches half around 
the age of 60 [2, 21,22,26]. 
 
Geroprotectors 
 
Lifespan  extension  possibility  was 
experimentally  demonstrated  for  many 
geroprotector  substances,  including 
antioxidants  [75],  latirogene,  chelating 
agents  (carnosine  [53]),  adaptogens, 
neurotropes,  monoamine  oxidase 
inhibitors,  dehydroepiandrosterone,  sexual 
hormones,  growth  hormone,  melatonin 
[50],  preparations  from  the  pineal  gland, 
protease  inhibitors,  antidiabetic  agents, 
thymic  hormones,  immunomodulators, 
superoxide  dismutase  and  catalase 
mimetics, enterosorbents, etc. [47].  
There  are  not  yet  geroprotectors  with  
unquestioned  efficiency,  and  in  some 
cases,  supposed  geroprotector  substances 
had  proved  long  term  effects  difficult  to 
predict initially [2, 79].  
In  the  past  years,  a  new  area  of  the 
gerontology  becomes  important,  that  of 
studying  the  so  called  hormesis 
mechanisms  by  which  substances 
classified  as  toxic  or  very  harmful,  in 
subliminal  doses,  may  have geroprotector 
effects;  currently  numerous  scientific 
investigations are undertaken in this regard 
[2]. 
Reducing calorie intake [177, 192] has 
been  shown  experimentally  to  induce 
certain anti-ageing behavior in a variety of 
species [31,32,33,58]. But for humans and 
other long-living animals, reducing calorie 
intake  interferes  with  many  other  genetic 
parameters and diet composition.  
Studying  the  mechanisms  by  which 
calorie  intake  reduction  influences 
senescence  and  longevity  rate  in 
experimental  animals  [82],  researchers 
have correlated this required behavior with 
reduced  plasma  levels  of  insulin  [81], 
increased  insulin  receptor  sensitivity,  low 
body  temperature,  cholesterol, 
triglycerides,  alpha-lipoproteins,  blood 
pressure  and  an  increase  in  HDL 
cholesterol.  Setting  all  these  processes  is 
experimentally  correlated  with  the 
expression of certain genes called sirtuins 
[96]  found  in  a  wide range of organisms 
from yeast to humans [39].  
In  2011  there  have  been  globally 
described 30 substances with geroprotector 
properties [2, 288], along side Gerovital - 
Romanian  geroprotector  product  prepared 
by  Prof.  Ana  Aslan  in  1951,  based  on 
anesthetic procaine, noteworthy resveratrol 
and other polyphenols of plant origin [30], 
Rapamycin,  antioxidants  (vitamins  A,  C 
and E, carotenoids, lipoic acid, coenzyme 
Q, selenium, etc.), hormones (GH, thyroid 
hormones and sexual hormones, melatonin 
[50]),  bioregulatory  peptides  (timalin, 
epithalmin),  biguanides  (metformin, 
fenformin)  [77],  and  adaptogens  (ginseng 
[48]).  
Scientific reports show that biguanides, 
particularly metformin [56-77], used in the 
treatment  of  type  2  diabetes  due  to  their 
ability  to  inhibit  gluconeogenesis  and  to 
determine  the  increase  of  sensitivity  to 
insulin,  may  also  have  geroprotective 
effects [56, 98]. 
Sirtuins  are  NAD
+-dependent  protein 
deacetylases  regulating  metabolism  and 
ageing processes, and they were suggested 
to  mediate  lifespan-extending  effects  of 
caloric restriction.  They were discovered 
in  Saccharomyces  cerevisiae,  and  have 
attracted interest due to their involvement 
in lifespan extension, age-related disorders, 
obesity,  heart  disease,  neurological 
function  and  cancer  [36].  In  mammals 
sirtuins family consists of seven genes of 
this type, called Sirt1 to Sirt7 [35]. Recent 
researches seek to identify their role in cell 
physiology  and  mechanisms  or  molecular 
agents, and ways of how their activity can 
be influenced [31, 32, 35,105]. 
Sirolimus  or  rapamycin,  described  as 
immunosuppressive  and  antitumoral  drug  
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has been shown to be also an anti-ageing 
drug [41] whose goal is the TOR gene in 
yeast [43] and mTOR gene, its mammalian 
correspondent,  also  known  as  FK506 
factor or FRAP1, a serine/threonine kinase 
that  regulates  cell  growth,  viability, 
mobility,  protein  synthesis  and  gene 
transcription  [31,45,78].  Rapamycin, 
according  to  recent  studies,  may  act 
preventively in atherosclerosis, hypertonia 
and  hypercoagulation,  thus  preventing 
myocardial  infarction,  cardiovascular 
accidents,  osteoporosis,  cancer, 
autoimmune  diseases,  arthritis,  fat 
diabetes,  Alzheimer  and  Parkinson 
diseases [31,42,45]. 
Antioxidants  such  as  α-tocopherol, 
ascorbic  acid,  retinol,  ubiquinone, 
selenium,  as  endogenous  compounds  or 
numerous synthetic molecules, intervene in 
gerossuppression based on the ageing free 
radical  theory  [87].  Resveratrol  (3,5,4’-
trihydroxy-trans-stilbene)  is  the  best 
known current geroprotector, discovered in 
2003, present in high concentrations in the 
epicarp,  seeds  and  stalk  of  grapes  (Vitis 
vinifera)  and  subsequently  in  red  wine 
[30,33],  and  in  roots  of  Polygonum 
cuspidatum. It is a natural phytoalexin used 
by  certain  plants  in  defense  mechanism 
against  pathogens  such  as  bacteria  and 
fungi,  currently  extensively  studied,  and 
that can influence the expression of sirtuins 
[34,35,37,102]. Since its discovery in 2003 
until  today  there  were  registered 
worldwide over 2,000 experimental studies 
on  resveratrol,  and  several  laboratories 
dedicate  their  work  to  the  study  of  this 
substance [2]. 
Preclinical studies [103] on resveratrol 
demonstrated an increase in the longevity 
of S. cerevisiae of 70% by cultivation in a 
medium containing 10 mM resveratrol, of 
20% in C. elegans and 29% in Drosophila 
melanogaster  by  treatment  with  100  mM 
resveratrol [39,40]. In studies on laboratory 
mice, resveratrol at doses around 20 mg/kg 
caused  a  statistically  significant  decrease 
of  age-related  parameters  such  as 
albuminuria,  the  inflammatory  level, 
vascular endothelial apoptosis, decreases in 
the elasticity of the aorta, the incidence of 
cataract,  etc.,  being  inclusively  registered 
data  towards  the  decrease  of  genetic 
instability [2]. 
On  MRC5  human  fibroblasts,  the 
resveratrol  in  concentration  of  5  µm 
induced  a  significant  protection  of  DNA 
oxidative  deterioration,  preventing  the 
growth  of  nuclear  volume,  reducing  the 
generation of acetylated forms of H3 and 
H4  histones  and  p53  protein.  In  another 
study  on  human  fibroblasts,  using  a 
concentration  of  10  µm  and 25 µm have 
been obtained data supporting the delay in 
the morphological alterations at the cellular 
level correlated with age [2].  
It is supposed that polyphenols such as 
resveratrol  inhibits  senescence  at  the 
cellular  level  by  activating genes such as 
p53 and AKT [39], sirtuins or inhibition of 
others,  like  mTOR  [46].  These  influence 
different  intracellular  signaling  pathways 
by which are controlled the expression of 
genes  involved  in  cell  growth,  the 
proliferation  and  cell  viability  [34]. 
Clinical trials regarding resveratrol action 
in oncology that used a commercial form 
of  resveratrol  called  SRT501  showed  a 
39%  increase  in  apoptosis  of  malignant 
cells in patients with metastatic colorectal 
cancer  [2,  194,  195].  Neuroprotective 
effects  of  resveratrol  [30,35]  have  been 
described  in  experimental  studies  on 
laboratory  mice  and  were  explained  by 
researchers by the effect of resveratrol of 
increasing  the  cysteine  level  that  can 
protect  cells  from  oxidative  stress  by 
regulating  proteic  precursors  of  amylase 
plate  [38].  Resveratrol  acts  also  on 
manganese  superoxide  dismutase 
(MnSOD)  a  group  of  enzymes  that 
degrades  metabolic  generated  superoxide 
molecules  thus  having  antioxidant  effect 
[80]. 
Cardioprotective  effects  of  resveratrol 
[30,36], as well as the other polyphenolic 
antioxidants such as quercetin or catechins, 
was  observed  in  in  vitro  studies  that 
showed  a  reduction  of  cardiomyocyte  
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apoptosis  by  decreasing  the  level  of 
caspase-3  and  other  cytokines,  including 
NF-KB2, E-selectin, TNF-α or troponin [2, 
224].  
Resveratrol  also  has  an  anti-
inflammatory  effect  [30,33],  resulting  in 
decreased activity of cyclo-oxygenase with 
a  key  role  in  the  synthesis  of  other 
cytokines such as IL17. Resveratrol acts on 
the cellular mechanisms involved in photo-
ageing  correlated  with  UV  action, 
including  MAP  kinases,  NF-kB  nuclear 
factor and matrix metalloproteins. External 
applications  of  resveratrol  in  SKH-1 
hairless mice model prior to UV exposure 
caused  a  significant  reduction  of  cell 
proliferation,  protection  mRNA  and 
phosphorylation [30]. The theory of using 
antidiabetics  like  resveratrol  [30]  is 
explained  by  indirectly  activating  SIRT1 
and  subsequent  increase  in  sensitivity  to 
insulin  [32],  improving  microcirculation 
and  peripheral  nerve  function  [2].  The 
pharmacology  of  resveratrol  [34]  is  still 
marked by a number of limitations, having 
a  low  solubility  in  water  (only  0,03g/L) 
and consistently a low bioavailability and 
stability,  being  easily  oxidized  in  the 
presence  of  light  or  heat.  There  are  also 
data  of  some  authors  that  contradict  the 
fact  that  resveratrol  would  determine  the 
extent  of  longevity  [280],  obtained  on 
Drosophila  melanogaster  and  C.  elegans 
[36]. 
Among  the  many  hormones  above 
mentioned with geroprotector effects [49], 
greater relevance for this project have the 
substances  with  similar  actions  of  sexual 
hormonesn. Substances such estrogen-like, 
testosterone-like, which stimulate or inhibit 
various  neuroendocrine  mechanisms  [49] 
are detected in the organic component of 
therapeutical  peloids  and  their 
geroprotective  action  is  currently 
intensively studied. The testosterone serum 
level  gradually  decreases  along  with  the 
advancing in age which causes progressive 
muscle  atrophy,  fatigue,  osteoporosis, 
reduced sexual function and increased fat 
levels. These symptoms can be treated by 
administration of testosterone [22], which 
has as effect, in addition to a recovery of 
lipid  levels,  also  a  decrease  of  
concentration of plasma glucose correlated 
with  increased  sensitivity  to  insulin.  The 
last  half  of  the  century  allowed  due  to 
numerous  scientific  results,  the  use  of 
estrogen  in  postmenopausal  women  to 
prevent  signs  of  ageing,  such  as 
osteoporosis,  cardiovascular  diseases, 
decrease  sexual  and  cognitive  functions 
[52].  However,  the  enthusiasm  was 
diminished  by  recent  publications 
indicating  the  risks  of  using  estrogen, 
including  breast  cancer,  pulmonary 
embolism,  stroke  and  coronary  heart 
disease [2, 55]. 
Free  radicals  are  continuously 
produced in the human body, as they are 
essential for energy supply, detoxification, 
chemical  signaling  and  immune  function 
[277]. Ultraviolet light, ionizing radiation, 
chemical  reactions  and  metabolic 
processes  can  induce  the  production  of 
reactive oxygen species (ROS) in the cells. 
Free radicals can initiate the oxidation of 
bio-molecules,  such  as  protein,  lipid, 
amino acids and DNA, which will lead to 
cell  injury  and  can  induce  numerous 
diseases.  An  imbalance  between 
antioxidants  and  reactive  oxygen  species 
results  in  oxidative  stress,  leading  to 
cellular  damage.  Oxidative  stress  is  the 
main  cause  of  several  diseases:  cancer, 
cataracts,  age-related  diseases  and 
Parkinson’s disease [208, 214, 222, 225]. 
Air pollutant such as car exhaust, cigarette 
smoke,  and  industrial  contaminants 
encompassing  many  types  of  NO 
derivatives  constitute  major  sources  of 
ROS that attack and damage the organism 
either  by  direct  interaction  with  skin  or 
following  inhalation  into  the  lung  [83]. 
Drugs  are  also  a  major  source  of  ROS 
[84,85].  One  of  the  major  sources  of 
oxidants  is  food,  which  often  contains 
different  kinds  of  oxidants  such  as 
peroxides, aldehydes, oxidized fatty acids, 
and reactive species catalysts (transitional 
metals) [86]. Food debris that reaches the  
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intestinal  tract  places  an  enormous 
oxidative  pressure  on  the  intestinal-tract 
mucosa [89]. Although the exposure of the 
organism to ROS is extremely high from 
exogenous  sources,  the  exposure  to 
endogenous  sources  is  much  more 
important  and  extensive,  because  it  is  a 
continuous process during the life span of 
the organism [90]. 
Enzymes comprise another endogenous 
source  of  ROS.  While  most  enzymes 
produce  ROS  as  a  by-product  of  their 
activity,  exemplified  by  the  formation  of 
superoxide  radicals  by  xanthine  oxidase, 
there  are  some  enzymes  designed  to 
produce ROS, such as nitric oxide synthase 
that yields NO radicals, thos that produce 
H2O2,  and  those  responsible  for 
hydroxylation  [93].  Blood  cells,  except 
erythrocytes  (neutrophils,  eosinophils, 
basophils,  monocytes  and  lymphocytes), 
possess  mechanisms  to  combat  bacteria 
and other invaders by ROS production that 
act  synergistically  with  exogenous  ROS 
and NADPH serves as a donor of electrons 
to an activated enzymatic complex in the 
plasma  membrane  (NADPH-oxidase 
complex)  to  produce  superoxide  radicals 
from  the  oxygen  molecule.  Following 
dismutation, the production of H2O2 leads 
to  the  formation  of  OH
•  by  the  metal-
mediated, Haber-Weiss reaction [51].  
Molecular oxygen is required to sustain 
life,  but  it  can  be  toxic  through  the 
formation  of  reactive  oxygen  species 
(ROS).  ROS  includes  superoxide  radical, 
hydroxyl radical, singlet oxygen and H2O2, 
which  have  been  found  to  play  an 
important  role  in  the  initiation  and/or 
progression  of  various  diseases  such  as 
atherosclerosis,  inflammatory  injury, 
cancer and cardiovascular disease [209]. 
In several normal conditions ROS are 
produced  and  play  a  role  in  the 
pathogenesis  of  the  physiological 
condition.  Literature  data  show  that 
numerous  pathologies  and  disease  states 
serve  as  sources  for  the  continuous 
production  of  ROS  and  more  than  200 
clinical  disorders  have  been  described  in 
which ROS (as initiators or as mediators) 
were important for the initiation stage of a 
disease or produced during its course (e.g. 
cancer,  heart  diseases,  endothelial 
dysfunction,  atherosclerosis  and  other 
cardiovascular  disorders,  inflammation, 
burns,  intestinal  tract  diseases,  brain 
degenerative  impairments,  diabetes,  eye 
diseases,  and  ischemic  and  postischemic 
pathologies  [94].  Other  pathological 
disorders,  which  are  associated  with 
impaired  metal  metabolism,  such  as 
hemochromatosis,  Wilson  disease  and 
thalassemia, in which iron is deposited in 
many  organs,  are  known  to  increase 
significantly  the  concentration  of  ROS. 
Also,  these  are  exemplified  during  the 
aging  process  where  ROS  production 
significantly  increases  as  a  result  of 
impaired mitochondrial function and in the 
early  stages  of  embryonic  development 
[51]. 
Organisms  have  multiple  mechanisms 
to protect cellular molecules (DNA, RNA 
and  proteins)  against  ROS-induced 
damage.  These  include  repair  enzymes 
(DNA  glycosylases,  AP  endonucleases 
etc), antioxidant enzymes (SOD, catalase, 
and  glutathione  peroxidase),  and  intra  as 
well  as  extracellular  antioxidants 
(glutathione,  uric  acid,  ergothioneine, 
vitamin  E,  vitamin  C  and  phenolic 
compounds.  However,  this  natural 
antioxidant  mechanism  can  be  inefficient 
for severe and/or continued oxidative stress 
[209]. 
Nutritional  deficiencies,  impaired 
digestion,  poor  circulation,  insulin 
resistance, smoking, and chronic stress all 
can  contribute  to  diminished  cerebral 
function  and  may  be  part  of  the 
Alzheimer’s puzzle. No one has discovered 
Ponce  de  Leon’s  Fountain  of  Youth,  but 
we do know that herbs, diet, lifestyle, and 
supplements  can  slow  ageing,  enhance 
memory,  help  prevent  cancer  and  heart 
disease, and keep us as healthy as possible 
throughout our lives. In this project we will 
focus  on  common  conditions  associated 
with ageing and examine a range of herbal  
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and  nutritional  therapies  that  can  help 
[216].  
Herbal  formulations  have  been in use 
for  many  years  globally  not  only  as 
therapeutic  but  also  as  prophylactic  and 
health  promotive  agents.  Sea  buckthorn 
(Hippophae rhamnoides L.), a unique and 
valuable  plant  has  recently  gained 
worldwide  attention,  mainly  for  its 
medicinal  and  nutritional  potential.  Sea 
buckthorn  is  a  thorny  nitrogen-fixing 
deciduous shrub of cold arid region native 
to  Europe  and  Asia.  It  is  currently 
domesticated in several parts of the world 
due  to  its  nutritional  and  medicinal 
properties.  All  parts  of  this  plant  are 
considered  to  be  a  good  source  of  large 
number  of  bioactive  substances  like 
vitamins  (A,  C,  E,  K,  riboflavin,  folic 
acid), carotenoids, phytosterols (ergosterol, 
stigmasterol,  lansterol,  amyrins),  organic 
acids  (malic  acid,  oxalic  acid), 
polyunsaturated  fatty  acids  and  some 
essential amino acids [109, 168, 169, 172, 
243, 223, 227]. 
Antioxidants  reduce  the  oxidative 
stress  in  cells  and  are  therefore useful in 
the  treatment  of  many  human  diseases, 
including  cancer,  cardiovascular  diseases 
and inflammatory diseases. This activity is 
due to the ability of antioxidants to reduce 
oxidative  stress  by  neutralizing  or 
scavenging of reactive species by hydrogen 
donation.  Medicinal  plants  contain  some 
organic  compounds,  which  produce 
definite physiological action on the human 
body,  and  these  bioactive  substances 
include  tannins,  alkaloids,  carbohydrates, 
terpenoids,  steroids  and  flavonoids.  They 
are  of  great  importance  to  the  health  of 
individuals  and  communities.  Many  of 
these indigenous medicinal plants are used 
as  spices  and  food  plants 
[208,210,218,222,229].  
Phenolics have been known to possess 
a  capacity  to  scavenge  free  radicals.  The 
antioxidant  activity  of  phenolics  is 
principally  due  to  their  redox  properties, 
which  allow  them  to  act  as  reducing 
agents,  hydrogen  donors.  Phenolics  are 
especially  common  in  leaves,  flowering 
tissues and woody parts, such as stems and 
barks [208, 211, 212,220]. Although it is 
still  early  to  define  their  exact  clinical 
benefits for treating age-related disease, a 
diet rich in polyphenolic or other forms of 
antioxidants  does  seem  to  offer  hope  in 
delaying the onset of age-related disorders. 
It  is  now  clear  that  any  deficiency  in 
antioxidant vitamins, inadequate enzymatic 
antioxidant defenses can be distinctive for 
many  age-related  disease,  and  protein 
carbonylation can be used as an indicator 
of  oxidative  stress  associated  to  diseases 
and ageing status [213].  
 
Mud and healthy ageing 
 
The liquid phase of mud constitutes a 
hypertonic  solution  of  minerals,  organic 
humic  substances,  bituminous, 
carbohydrates,  peptones,  amino  acids  and 
enzymes. Since 1957 V.D. Narti proposed 
the utilization of natural solutions of this 
therapeutic  mud,  besides  classical 
procedures  with  mud.  The  solution 
envisaged by Narti, "PELOIDEXTRACT",  
was extracted by filtration under pressure 
of  6-12  atmospheres  of  inert  gas  (CO2). 
The  solution  obtained  from  Techirghiol 
mud is a clear liquid, stable, with a density 
of 1.062 at 21°C, with an alkaline pH of 
7.6  to  8,  and  mineral  content  closely 
comparable to that of blood serum, except 
SO42-and Mg2 +, which are in excess. The 
natural  solution  would  be  a  hypertonic 
solution 10 times more concentrated than 
blood serum. 
For cellulite treatment extracted mud is 
mixed to form a cream with plant extracts 
and bioactive substances [120, 215, 217]. 
In  psoriasis,  seborrheic  and  atopic 
dermatitis, eczema and first degree burns is 
used a cream containing 1-6% suspension 
of  mud  as  active  ingredient  [121].  In 
addition, the mud suspension may be used 
to  create  dermal  application  dressings 
[122, 123]. The mud is composed of humic 
substances,  pectin,  cellulose  and  lignin, 
waxes,  resins  and  inorganic  materials  
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[124],  also  including  identified  structures 
such as alkanes, 4-phenyl valeric acid, 5-
isopentyl  picolinic  acid,  33hydroxylauric 
acid,  (5α,  3β)-3-hydroxy-11-androstanon, 
5α-2-ene-11-androstenone,  squalene,  α 
terpineol, menthol derivates, palmitic, oleic 
and  eicosanoic  acid  and  the  isoprenoid 
phytan [125].  
Patent  No116867B  since  1996 
requested  by  the  SC  "BIOTEHNOS"  SA 
Bucharest describes a peloid-extract, which 
is  based  on  sapropelic  mud  from 
Techirghiol  Lake,  characterized  as  a 
slightly-yellow  colored  liquid,  slightly 
opalescent, odorless, with total salt: 116.4 
to 118.3 g/l, mineral residue 75 to 80 g/l, 
Na
+ from 24.3 to 25.0 g/l, K
+ 0.7 to 0.9 g/l, 
Ca
2+ from 0.08 to 0.19 g/L, Mg
2+ 2.9 to 3.4 
g/L, HCO3
- 0.2 to 0.65 g/L, Cl
- 39.4-41.4 
g/l, SO4
2- 7.1-10.9 g/l, carbohydrates, lipids 
and proteins detection limit level and anti-
hyaluronidase  activity  of  minimum 
30UI/ml. The peloid extract is in the form 
of a white powder, amorphous, with anti-
inflammatory,  antiseptic  and 
anticongestive  properties  having  a  pH 
between  7.6  and  7.8,  a  rH  of  8.2  and  a 
density  of  2.011,  composed  of  53.18% 
water-insoluble  minerals  which  contain 
0.2%  magnesium  silicate,  0.54%calcium 
silicate,  0.03%  iron  silicate  and  1.74% 
aluminium  silicate.  Pharmaceuticals  used 
in cosmetics or in the treatment of various 
pathologies  is  based  on a total extract of 
mud, sometimes being fractionated. Thus, 
there are cosmetic preparations for which 
the  active  compounds  from  the  mud  are 
extracted  using  mixtures  of 
paraffin/ethanol/dimethicone  or  a  mixture 
of  water/ethanol,  or  one  containing 
water/ethanol  /  glycerol/propylene  glycol 
[119]. 
Humic compounds play a role in redox 
reactions,  absorption,  complexation  and 
transport  of  substances,  supporting 
structure and formation of mud and control 
the carbon biogeochemistry in ecosystems 
[126]. Humic compounds can be classified 
into three fractions based on solubility in 
water at different pH values. Humic acid is 
soluble in alkaline solutions fraction, fulvic 
acid is soluble in water fraction regardless 
of pH and the humine fraction is insoluble 
in  water  [127,128].  Humic  acids  are 
compounds  having  a  molecular  weight 
between  10,000  and  100,000  with 
structures  containing  aromatic  ring 
structures  with  nitrogen  atoms,  aliphatic 
and peptide residues.  
Humic acid [257, 310] containing 56% 
C, 5.5% H, 4% N and 33% O, the major 
functional  groups  present  being  COOH-, 
OH-  phenol  and  ketone  groups  [129]. 
Humic  acids  have  an  astringent  effect 
[352],  adrenaline  and  dopamine  receptor 
agonist,  anti-allergic,  antibacterial, 
anticoagulant, anti-inflammatory, antiviral, 
estrogen,  hemostatic,  hyperemic,  UVB-
protective [123, 342] and are heavy metal 
chelating-agents  [129,130,131].  In  rats 
treated  with  natural  mud  or  mud  humic 
acids  extracted  from  mud,  a  decrease  in 
total  cholesterol,  total  lipids  and  blood 
glucose  and  increased  LDH, 
immunoglobulins,  erythrocytes, 
hemoglobin  and  hematocrit  was observed 
[132, 297]. Humic acids can be extracted 
and  purified  using  the  method  based  on 
pyrophosphate-  sodium  hydroxide 
[128,133,134,137] or ionic liquids such as 
dimethyl  ammonium  dimethylcarbamate 
and  1-butyl-3-methylimidazole  chloride 
[136]. 
Fulvic  acids  are  oxidized  substances 
with  aromatic  structures  characterized  by 
extensive lateral aliphatic chains having a 
lower nitrogen content compared to humic 
acids  [127,  336].  Fulvic  acids  have  anti-
allergic effect [137,138], show antioxidant 
[139] and antimicrobial activity [140, 284], 
reduce cutaneous immune response [141], 
are antitumoral [142] and antiseptic [143], 
acting  in  acid  medium  by  inhibiting 
mitochondrial respiration in Candida utilis 
[144],  being  used  in  the  treatment  of 
eczema  [145],  have  antiulcerogenic 
properties  [146]  and  precognitive  so  they 
can  be  used  to  treat  Alzheimer's  disease 
[147],  not  having  adverse  effects  on  the 
body  in  small  doses  [148].  According  to  
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the  method  of  the  International  Humic 
Substances  Society  [149]  fulvic  acids are 
separated from the acidified supernatant of 
an  alkaline  extract  of  mud  using 
polymethyl  methacrylate-based  resins 
DAX-8  [150]  or  XAD-8  [151]  based  on 
hydrophobic  interactions  between  fulvic 
acids  and  these  resins.  Other  ion 
exchangers are used for the separation of 
fulvic  acids  are  diethylaminoethyl 
cellulose  and  polivinilpyrolidone  [152, 
302].  Also,  fulvic  acids  are  separated  by 
ion pair formation with cationic surfactants 
such  as  cetyltrimethylammonium 
benzildimethylhexadecylammonium 
bromide,  dodecylethyldimethylammonium 
chloride [153].  
The humic substances have functional 
groups available for the binding of metallic 
elements  [110]  such  as  Cu²
+  [108],  Cd
2+ 
[107,106],  and  also  transuranic  elements 
(Pu  and  Am)  [100].  A  study  of  stability 
constant  indicated  that  Am(III)  had  the 
strong  interaction  with  humic  acid,  [99] 
and fulvic acids interact with Cu
2+, Zn
2+, 
Mn
2+ [472] and U
4+ or UO2
2+ [101]. 
Lipid fraction [219, 328] of the mud is 
defined  as  organic  material  insoluble  in 
water and can be solubilized and extracted 
using  apolar  organic  solvents  such  as 
hexane,  benzene,  chloroform,  and  diethyl 
ether [154].  
This ratio is of 0.2 to 5% of the mud 
and  include  fatty  acids  [219],  sterols, 
terpenes,  hydrocarbons,  chlorophyll,  fats, 
waxes  and  resins  [155].  The  lipids  from 
mud can be extracted by Soxhlet method 
using a mixture of benzene/methanol [156] 
or  dichloromethane/methanol  [157]  or  by 
the Bligh-Dyer method with a mixture of 
chloroform  /  methanol  [158].  Another 
fraction  of  mud  being  of  therapeutic 
interest  consists  of  protein  hydrolysates, 
amino acids, enzymes (amylase (EC 3.2.1), 
arylsulfatase  (EC  3.1.6.1),  β-glucosidase, 
cellulase  (EC  3.2.1.4),  chitinase, 
dehydrogenase,  phosphatase  (EC  3.1.3), 
protease, urease) and carbohydrates [159], 
which are released from the complex with 
humic substances by acid hydrolysis [160] 
and concentrated by reverse osmosis [161 
162].  
Combining  the  best  fractions  of  mud 
[358]  obtained  will  result  in  getting  the 
mud extract that will be used to obtain the 
new  healthy-ageing  products  by  adding 
plant extracts in a xylitol matrix. Xylitol is 
a five carbon sugar alcohol that naturally 
occur in foods such as fibrous vegetables 
and  fruit.  It  is  a  natural,  intermediate 
product  which  regularly  occurs  in  the 
glucose  metabolism.  Xylitol  is  produced 
naturally in our bodies; in fact, we make up 
to  15  grams  daily  during  normal 
metabolism.  Xylitol  has  40%  fewer 
calories than sugar [54]. 
All the above data about life extension, 
geroprotectors,  peloid  and  plant 
components,  antioxidants,  diet  elements 
and phytochemicals constitute the general 
scientific  bacground  from  which  the 
proposal  goes  on,  looking  to  combine 
selected  fractions  of  peloid  and  plants  in 
new  healthy  ageing  products  and  to  test 
them on animals, cells and humans [226]. 
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